Literature DB >> 10474683

Malignant fibrous histiocytomas and H-ras-1 oncogene point mutations.

P Rieske1, J Bartkowiak, A Szadowska, M Debiec-Rychter.   

Abstract

AIMS: To investigate the types and the frequencies of H-ras-1 gene mutations in malignant fibrous histiocytomas.
METHODS: Thirty five samples of malignant fibrous histiocytoma tissue were searched for point mutations within "hot spot" codons 12 and 13 of the H-ras-1 oncogene by the specific "nested" polymerase chain reaction followed by restriction fragment length polymorphism (PCR-RFLP) and a direct cycle sequencing procedure.
RESULTS: In contrast to previous reports, none of the tumours contained a point mutation or any other changes within or around the hot spot gene sequences.
CONCLUSIONS: These data indicate that H-ras-1 oncogenic activation is not required in the molecular pathway of malignant fibrous histiocytoma formation and cannot be used as a discriminating factor for diagnostic sarcoma typing.

Entities:  

Mesh:

Year:  1999        PMID: 10474683      PMCID: PMC395675          DOI: 10.1136/mp.52.2.64

Source DB:  PubMed          Journal:  Mol Pathol        ISSN: 1366-8714


  27 in total

Review 1.  Cytogenetics and molecular genetics of bone and soft tissue tumors.

Authors:  N Mandahl
Journal:  Adv Cancer Res       Date:  1996       Impact factor: 6.242

2.  Single somatic ras gene point mutation in soft tissue malignant fibrous histiocytomas.

Authors:  R M Bohle; S Brettreich; R Repp; A Borkhardt; H Kosmehl; H M Altmannsberger
Journal:  Am J Pathol       Date:  1996-03       Impact factor: 4.307

3.  Comparison of ras activation in prostate carcinoma in Japanese and American men.

Authors:  N Konishi; Y Hiasa; T Tsuzuki; M Tao; T Enomoto; G J Miller
Journal:  Prostate       Date:  1997-01-01       Impact factor: 4.104

4.  ras gene mutations in human endometrial carcinoma.

Authors:  M N Varras; M Koffa; E Koumantakis; M Ergazaki; E Protopapa; S Michalas; D A Spandidos
Journal:  Oncology       Date:  1996 Nov-Dec       Impact factor: 2.935

Review 5.  Molecular genetics and cytogenetics of sarcomas.

Authors:  R P Kruzelock; M F Hansen
Journal:  Hematol Oncol Clin North Am       Date:  1995-06       Impact factor: 3.722

Review 6.  Recent developments in soft tissue tumors.

Authors:  J R Goodlad; C D Fletcher
Journal:  Histopathology       Date:  1995-08       Impact factor: 5.087

7.  Pancreatic cancer in Europe: Ki-ras gene mutation pattern shows geographical differences.

Authors:  A Scarpa; P Capelli; A Villaneuva; G Zamboni; F Lluìs; R Accolla; G Mariuzzi; G Capellà
Journal:  Int J Cancer       Date:  1994-04-15       Impact factor: 7.396

8.  p53 and Ki-ras gene mutations in epithelial ovarian neoplasms.

Authors:  M G Teneriello; M Ebina; R I Linnoila; M Henry; J D Nash; R C Park; M J Birrer
Journal:  Cancer Res       Date:  1993-07-01       Impact factor: 12.701

Review 9.  The multistep nature of cancer.

Authors:  B Vogelstein; K W Kinzler
Journal:  Trends Genet       Date:  1993-04       Impact factor: 11.639

10.  Multiple Ras functions can contribute to mammalian cell transformation.

Authors:  M A White; C Nicolette; A Minden; A Polverino; L Van Aelst; M Karin; M H Wigler
Journal:  Cell       Date:  1995-02-24       Impact factor: 41.582

View more
  2 in total

1.  Atypical molecular background of glioblastoma and meningioma developed in a patient with Li-Fraumeni syndrome.

Authors:  Piotr Rieske; Magdalena Zakrzewska; Wojciech Biernat; Jacek Bartkowiak; Arthur Zimmermann; Paweł Piotr Liberski
Journal:  J Neurooncol       Date:  2005-01       Impact factor: 4.130

2.  Dual Pten/Tp53 suppression promotes sarcoma progression by activating Notch signaling.

Authors:  Maria V Guijarro; Sonika Dahiya; Laura S Danielson; Miguel F Segura; Frances M Vales-Lara; Silvia Menendez; Dorota Popiolek; Khushbakhat Mittal; Jian Jun Wei; Jiri Zavadil; Carlos Cordon-Cardo; Pier Paolo Pandolfi; Eva Hernando
Journal:  Am J Pathol       Date:  2013-06       Impact factor: 4.307

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.